Evidence map›Paper›PMID 41948254›Full record

ReviewCureus2026

Role of Posterior Tibial Slope Osteotomy in Revision Anterior Cruciate Ligament Reconstruction: A Narrative Review.

Javier Gonzalez Almonacid

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Javier Gonzalez AlmonacidOrthopedics, Hospital Clínico San Borja Arriarán, Santiago, CHL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Failure after anterior cruciate ligament (ACL) reconstruction remains a significant clinical challenge, particularly in the revision setting. Among biomechanical factors, increased posterior tibial slope (PTS) is an important factor to consider during the preoperative evaluation of patients undergoing revision ACL reconstruction. A narrative review of the current literature was performed to analyze the biomechanical and clinical role of PTS in ACL graft failure. Emphasis was placed on revision ACL reconstruction, including the biomechanical rationale for slope correction, proposed threshold values, surgical indications, and reported clinical outcomes of slope-reducing osteotomy. A representative clinical case is presented to illustrate the application of these concepts in practice. Biomechanical studies consistently demonstrate that increased PTS leads to higher anterior tibial translation and increased ACL graft forces under axial loading. Clinical evidence supports an association between pathological PTS, most commonly values ≥12°, and increased rates of ACL graft failure in both primary and revision reconstructions. In selected revision cases, slope-reducing proximal tibial osteotomy has been shown to decrease graft loading, improve knee stability, and reduce the risk of recurrent failure. However, available clinical data remain limited and are primarily derived from case series and cohort studies. PTS represents a clinically relevant and potentially modifiable risk factor in revision ACL reconstruction. Slope-reducing osteotomy should be considered as part of a targeted revision strategy in carefully selected patients with pathological PTS, particularly when values exceed 12°. This procedure should not be applied routinely, but rather integrated into a comprehensive revision approach based on individual biomechanical and clinical factors.

Indexed as

anterior cruciate ligamentknee biomechanicsposterior tibial sloperevision acl reconstructionslope-reducing osteotomy

Identifiers

PMID41948254
PMCPMC13051244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.